06.20.24 -- Unlocked Potential: How Digital Patient Twins Revolutionize Clinical Research

Industry experts share their perspectives on end-to-end clinical development, essential elements of a unified clinical platform, as well as the associated benefits and challenges involved.

Electronic modes have been shown to improve data quality in clinical trials. Address how equivalency can be achieved when migrating PROs from paper to ePRO.

Clinical trials generate reams of documents. Use an electronic trial master file to streamline much of the work of document management, logging, and compliance.

In 2024, McKinsey's projections foresee a promising year for the MedTech industry, driven by innovation but shadowed by regulatory uncertainty.

Access to RWD makes it possible to identify potential trial participants wherever they are, enabling researchers to reach diverse populations and enhance the representativeness of clinical studies.

Far too often, valuable data sources are siloed, disparate, and unusable. Learn how expansive datasets can empower the industry to advance clinical trials and outcomes research, benefiting all communities.

Get pragmatic details of what it took to build a successful partnership, why it has become a model for other departments within Regeneron, and lessons learned you can apply in your organization.